Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7MXI

IgE-Fc in complex with DARPins E2_79 and E3_53

7MXI の概要
エントリーDOI10.2210/pdb7mxi/pdb
分子名称IgE Fc, DARPin E3_53, Anti-IgE Inhibitor E2_79, ... (5 entities in total)
機能のキーワードige, darpin, allergy, inhibitor, immune system
由来する生物種Homo sapiens (Human)
詳細
タンパク質・核酸の鎖数6
化学式量合計125455.18
構造登録者
Pennington, L.F.,Jardetzky, T.J. (登録日: 2021-05-19, 公開日: 2021-07-28, 最終更新日: 2024-10-23)
主引用文献Pennington, L.F.,Gasser, P.,Brigger, D.,Guntern, P.,Eggel, A.,Jardetzky, T.S.
Structure-guided design of ultrapotent disruptive IgE inhibitors to rapidly terminate acute allergic reactions.
J.Allergy Clin.Immunol., 148:1049-1060, 2021
Cited by
PubMed Abstract: Anaphylaxis represents one of the most severe and fatal forms of allergic reactions. Like most other allergies, it is caused by activation of basophils and mast cells by allergen-mediated cross-linking of IgE bound to its high-affinity receptor, FcεRI, on the cell surface. The systemic release of soluble mediators induces an inflammatory cascade, rapidly causing symptoms with peak severity in minutes to hours after allergen exposure. Primary treatment for anaphylaxis consists of immediate intramuscular administration of adrenaline.
PubMed: 33991582
DOI: 10.1016/j.jaci.2021.03.050
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.8 Å)
構造検証レポート
Validation report summary of 7mxi
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon